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INTRODUCTION 
 
INTRODUCTION 
           Acute bronchiolitis, an acute infectious disease of the lower 
respiratory tract, which primarily affects the smaller airways. It is 
predominantly a viral respiratory disease. It is one of the leading causes 
of hospitalisation in infants and young children. It occurs usually between 
one month to 24 months of age with a peak incidence between 3 and 6 
months of age. Each year in the United States, approximately two per 
100,000 infants die as a result of complications associated with 
bronchiolitis1. In young children, the clinical diagnosis of this disease 
may overlap with viral wheezing and an acute viral triggered asthma. 
 
Epidemiology 
           Bronchiolitis occurs most frequently among children less than     
12 months of age. Infants less than 6 months are at increased risk of 
clinically severe disease2.  Bronchiolitis is a seasonal disease which 
coincides with outbreaks of viral respiratory pathogens. In temperate 
climates, the hospital admissions due to bronchiolitis are most common 
from December to May. In the United States (US), as many as one 
percent of infants are hospitalized for bronchiolitis and the annual 
hospital charges associated with bronchiolitis exceed 800 million3.      
The burden of respiratory syncytial virus (RSV) associated bronchiolitis 
was assessed recently. National data analysis revealed that more than 
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700,000 infants visit US emergency departments each year because of 
RSV bronchiolitis and approximately one third of these infants are 
admitted to the hospital4.  Environmental and genetic factors may 
contribute to the severity of disease. Daycare attendance, exposure to 
passive smoke and household crowding are associated with an increased 
risk of bronchiolitis related hospitalization5, 6. Race and poverty also have 
been associated with severe bronchiolitis4. Other studies have suggested 
that there might be a genetic predisposition to bronchiolitis.                   
For example, infants with bronchiolitis were more likely to have a family 
history of asthma or other allergic illness7.  
 Over the past 20 years, the rate of hospitalization for bronchiolitis 
has increased markedly8. Recent studies estimated that 2% to 3% of 
affected children required hospital admission9. Some authors have 
suggested that the widespread use of pulse oximetry monitoring in 
primary care practices and emergency departments might have 
contributed to this issue. Other factors, however, such as increased 
daycare attendance and increase in the number of medically fragile 
infants, might have led to real increases in the incidence of severe 
disease10.                      
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Etiology 
           Bronchiolitis is usually a consequence of viral respiratory tract 
infection. RSV is the most common underlying viral agent and has been 
isolated from 50% to 75% of children younger than two years of age 
hospitalized with bronchiolitis11. Other common respiratory viral 
pathogens, such as influenza, parainfluenza and adenovirus, have been 
isolated from children with bronchiolitis12, 13, 14. Recent investigations 
have demonstrated that some children with bronchiolitis may also be 
infected with rhinovirus15 or human metapneumovirus16, 17.               
 
 Finally, several studies have reported the recovery of 
Mycoplasma pneumoniae from infants with bronchiolitis, although this 
organism is not commonly recognized as a significant cause of disease in 
young children12. 
Causative agents 
i. Respiratory syncytial virus  
ii. Parainfluenza viruses    - Type 1  
                                                                        Type 2  
                                                                        Type 3  
iii. Adenoviruses  
iv. Mycoplasma pneumoniae  
v. Rhinoviruses 
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vi. Influenza viruses          - Type A 
                                                                      Type B 
vii. Enteroviruses 
viii. Herpes simplex virus  
ix. Mumps virus 
Pathogenesis 
           Bronchiolitis is a result of progressive infection and inflammation 
of the respiratory mucosa in a young child. The clinical symptoms of 
obstructive lower respiratory tract infection are a consequence of the 
partial occlusion of the distal airways. Histological examination of the 
lungs of affected children often reveals necrosis of the respiratory 
epithelium, monocytic infiltration with edema of the peribronchial tissues 
and obstruction of the distal airways with mucus and fibrin plugs.    
Infants are predisposed to develop wheezing and other symptoms of 
airway obstruction because of the small luminal calibre of their distal 
airways and the absence of active immunity to RSV and other respiratory 
viruses. Viral replication and viral induced production of inflammatory 
mediators by respiratory epithelial cells contribute to the pathogenesis of 
disease. After initial infection of respiratory epithelium of the upper 
airway in an immunologically naive child, viral replication can progress 
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to the mucosal surfaces of the lower respiratory tract. Desquamation of 
the respiratory epithelial cells, edema of the mucosal surface and 
enhanced reactivity of airway smooth muscle lead to the respiratory 
symptoms that characterize bronchiolitis. Some authors have reported 
that the clinical spectrum of the disease varies somewhat in association 
with the underlying viral pathogen15 and that these differences might 
reflect differences in the profile and extent of inflammatory mediators 
such as leukotrienes and cytokines produced by the infected respiratory 
epithelial cells18. The relationship between severe disease and               
co-infection with multiple respiratory viral agents remains unclear. 
Environmental factors also play a role in the development of 
bronchiolitis. It is unclear, however, how exposure to passive smoking 
might mediate an increased risk of disease or how household over 
crowding might be associated with an increased severity. 
Clinical presentation 
           An infant with bronchiolitis typically presents with illness during 
the winter months, although sporadic cases appear throughout the year. 
More than 50% of affected children are between 2 and 6 months              
of age19, 20. Parents often report that a child attends daycare or has a 
household contact with cold-like symptoms. Early in the illness, infants 
usually experience copious rhinorrhea. Typically, infants develop a tight 
cough associated with poor feeding 4 to 6 days after the initial onset of 
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symptoms. The proportion of infants with fever seems to vary with 
underlying pathogen. Overall, infants with respiratory syncytial virus 
(RSV) associated bronchiolitis are often febrile at the time of presentation 
for medical care. In patients with adenovirus or influenza associated 
bronchiolitis, the fever is often higher than 39.8oC. Infants with 
bronchiolitis often present for medical care with significant tachypnea, 
mild to moderate hypoxia, and signs of respiratory distress, such as nasal 
flaring and retractions19, 20. Upon examination, the infants typically have 
audible wheezing, rales or rhonchi, and poor air movement, and the 
expiratory phase is usually prolonged. Other findings commonly 
observed in children hospitalized with bronchiolitis include 
conjunctivitis, rhinitis, and otitis media. Many infants have a distended 
abdomen caused by hyperinflation of the lungs. Respiratory viral 
pathogens often can be isolated from infants hospitalized with 
bronchiolitis. However, the proportion of disease attributable to specific 
viral pathogen varies by season and year. Viruses can be isolated from 
nasal wash specimens by enzyme linked immunosorbent assays, indirect 
fluorescent antibody detection, polymerase chain reaction or viral culture. 
The results of viral diagnostic testing can be used to limit the 
inappropriate use of antibacterial therapy. But unfortunately these 
investigations are not widely available in developing countries like India. 
Infants with bronchiolitis often have mildly elevated total white blood 
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cell counts, although the differential cell count is typically normal19. 
Hypoxia is often observed on pulse oximetry or analysis of arterial blood 
gases. Retention of carbon dioxide can be seen in severe cases. 
Radiological findings of bronchiolitis include hyperinflation, patchy 
infiltrates that are typically migratory and attributable to post obstructive 
atelectasis and peribronchial cuffing19. Because bronchiolitis is not a 
disease of alveolar spaces, a secondary bacterial pneumonia should be 
suspected if a true alveolar infiltrate is seen on chest radiograph. 
Differential diagnosis 
           The absence of antecedent upper respiratory tract symptoms 
should suggest to clinicians that an infant with the acute onset of 
wheezing might not have bronchiolitis. In newborns, congenital 
anomalies, such as a vascular ring or congenital heart disease should be 
considered. Gastroesophageal reflux, aspiration pneumonia or foreign 
body aspiration can mimic the symptoms of bronchiolitis. 
Management 
           General supportive measures are the mainstay of management for 
bronchiolitis. The management of bronchiolitis consists of cardio 
respiratory monitoring, proper positioning to facilitate respiratory efforts 
(upright posture), and administration of humidified oxygen and possibly a 
trial of bronchodilators. Infants should be made as comfortable as 
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possible (held in a parent's arms or sitting in the position of comfort). 
Cardio respiratory monitoring is essential. Oxygen should be 
administered if the oxygen saturation is less than 94% on room air.  
           Because of tachypnea, partial nasal obstruction and feeding 
difficulties, young infants sometimes need intravenous fluids to correct 
dehydration. The use of bronchodilator therapy in the management of 
infants with bronchiolitis remains controversial9, 21-23. The inclusion of 
patients with history of recurrent wheezing has introduced bias into some 
studies and might have resulted in an overestimation of the potential 
benefit of bronchodilators. A recent meta-analysis found that in eight 
trials that included 394 children, 54% of patients treated with 
bronchodilators compared with 25% who received a placebo had an 
improved clinical score [OR(95%CI) = 0.29(0.19–0.45)]. Bronchodilator 
therapy was not associated with reduced need for or duration of 
hospitalization24. Similarly, a recent randomized, double-blinded, placebo 
controlled trial demonstrated that nebulized epinephrine did not shorten 
the duration of hospitalization25. A meta-analysis conducted by Hartling, 
et al26 also found insufficient evidence to support the use of nebulized 
epinephrine in hospitalized children. The role of steroids in the treatment 
of infants with bronchiolitis also has been controversial27.                    
A meta-analysis of six placebo controlled trials demonstrated that 
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corticosteroid therapy was associated with a significant reduction in the 
duration of hospitalization stay [OR (95%CI) = 0.43(0.05–0.81)]. 
However, if the studies that included patients with a history of recurrent 
wheezing were omitted from the analysis, this difference was no longer 
significant28. Dexamethasone also had no beneficial effect in children 
with respiratory failure caused by RSV bronchiolitis29. But, some studies 
have demonstrated that the use of steroids may be of benefit to infants 
with bronchiolitis if given before hospitalization30, 31. In a randomized, 
placebo controlled trial, Csonka, et al demonstrated that infants treated 
with oral prednisolone upon initial evaluation and during the first             
3 hospital days had a one day reduction in the duration of symptoms and 
length of hospital stay. Some clinicians have concluded that early 
treatment with steroids might shorten the duration of illness.  
RSV is the most common cause of bronchiolitis; however, specific 
antiviral therapy of symptomatic infants has been of limited value. 
Aerosolized ribavirin treatment of mild to moderately ill infants with 
laboratory confirmed RSV bronchiolitis does not prevent the need for 
mechanical ventilation or reduce the duration of hospital stay.     
American Academy of Pediatrics (AAP) does not recommend the routine 
use of ribavirin but suggests that ribavirin might be administered based 
on specific clinical circumstances and physician experience31.         
Patients who are at risk of persistent viral replication might benefit from 
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ribavirin therapy. Some experts recommend that ribavirin be considered 
when caring for severely immunocompromised patients who develop 
laboratory confirmed RSV associated bronchiolitis, such as children 
undergoing bone marrow transplantation32. Experts debate the role of 
ribavirin therapy for severely ill infants who require mechanical 
ventilation. In a single placebo controlled study, investigators found that 
infants treated with aerosolized ribavirin had a shorter duration of 
ventilation and of hospital stay33. Finally, investigators have yet to 
demonstrate that other therapies, including interferon, surfactant, vitamin 
A, mist therapy, or anticholinergics, have any measurable clinical effect. 
Epidemiologic data for under developed countries like ours are 
incomplete. Morbidity and mortality may be higher in poorly developed 
countries because of under nutrition and lack of resources for supportive 
medical care.  
Diagnosing bronchiolitis is important for preventing cross infection 
in the hospital and for epidemiological purpose. History and physical 
examination form the primary basis for the diagnosis of bronchiolitis 
because serological studies are not widely available in resource limited 
countries like India. In healthy infants and young children acute 
bronchiolitis is usually a self limited disease. Most of these children begin 
to improve within one or two weeks. But it can lead to severe disease and 
mortality in some children. 
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          Figure 1: Assessment and treatment of bronchiolitis34 
                                   Diagnosis: bronchiolitis 
                                                               ↓↓ 
                                   Assessment of severity 
       Mild             Moderate            Severe  
■ Normal ability to     
    feed               
■ Little or no  
    respiratory  
   distress               
■ Oxygen saturation  
    92 per cent or more  
    in room air. 
 
■ May appear short of breath  
    during feeding. 
■ Moderate respiratory distress,  
    with some chest wall  
    retractions, nasal flaring. 
■ Apnoeic episodes, usually  
    brief, self-limiting. 
■ Usually hypoxemic, corrected  
    (to SaO2 92 per cent or  
    higher) by oxygen. 
Symptoms of acute 
bronchiolitis with one or 
more of the following 
conditions, 
1.Poor feeding / Need for  
    intravenous hydration 
2.Severe respiratory  
   distress with marked  
    retractions, nasal flaring,  
    grunting 
3. hypoxemic, not  
    corrected (to SaO2 92  
    per cent or higher) by  
    oxygen. 
4.Need for mechanical  
    Ventilation 
                                      ↓↓ 
  
                                              Treatment:                                 
      Mild          Moderate            Severe  
1. Treat at home. 
2. Inform the parents  
    when to return. 
3. Review after  
    2days. 
1. Admit 
2. Maintain SpO2>92% with  
    oxygen supplementation. 
3. Careful oral feeds/IV fluids 
4. Chest X ray 
5. Watch for any deterioration 
1. Admit in ICU. 
2. Maintain SpO2 by oxygen  
    supplementation. 
3. Mechanical ventilation  
    if needed. 
4. NPO 
5. IV fluids. 
6. Chest x ray/ABG. 
7. Cardiorespiratory  
    monitoring. 
            
11 
 
Complications and outcomes 
           The case fatality rate for bronchiolitis is highest among infants 
between 1 and 3 months of age. Premature infants with birth weights less 
than 1500 g have a bronchiolitis mortality rate of 30 per 100,000 live 
births1. The presence of underlying medical illness, such as congenital 
heart disease or chronic lung disease, is another important predictor of 
poor outcome35. In these high risk children, the case fatality rate may be 
as high as 5%. Serious complications, including respiratory failure, apnea 
and pneumothorax, occur among infants hospitalized with bronchiolitis, 
more commonly among previous premature infants and infants with 
congenital anomalies. Overall, serious complications are associated with 
prolonged hospital stay and increased health care costs. The association 
between early bronchiolitis and asthma has been debated hotly36, 37.       
Up to 50% of children with a history of previous bronchiolitis develop 
recurrent wheezing37, 38. Some investigators have suggested that a family 
history of allergic or atopic disease correlates with the subsequent 
development of asthma. However, this association is incompletely 
understood39, 40.  
           Among healthy former premature infants, hospitalization for RSV 
bronchiolitis has been associated with an increase in subsequent use of 
health care resources, particularly those associated with respiratory 
conditions41. Subsequent health care visits for respiratory symptoms 
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occurred in 64% of infants previously hospitalized, compared with     
13% in infants not hospitalization for RSV bronchiolitis. For unclear 
reasons, secondary bacterial infections of the lower respiratory tract are 
unusual in infants with bronchiolitis42. It is estimated that one half to two 
thirds of children hospitalized for RSV bronchiolitis are febrile. 
Investigators in Texas demonstrated that children less than 2 years of age 
hospitalized for RSV bronchiolitis have a low rate of concurrent serious 
bacterial infections43. Two studies compared febrile RSV positive and 
RSV negative infants younger than 8 weeks of age. The rates of serious 
bacterial infections in RSV positive groups ranged from 1.1% to 7%, 
whereas the rate among RSV negative infants was 12.5% in both the 
studies. None of the RSV positive children had bacterial meningitis, and 
the predominant serious bacterial infection in these groups was urinary 
tract infection44, 45. Of note, infants younger than 28 days had rates of 
serious bacterial infections of 13.3%, regardless of RSV status45.        
Most children older than 1 month with typical signs and symptoms of 
bronchiolitis, especially children who are RSV positive, may not warrant 
full evaluation for invasive bacterial infection and may not require 
empiric antibiotic therapy at the time of hospitalization. The risk of 
urinary tract infection remains significant. In the first month of life, the 
risk of serious bacterial infections remains unchanged regardless of 
whether an infant is RSV positive or negative.  
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Prevention 
           A vaccine to prevent RSV infection in young children is needed. 
Despite several decades of effort, however, vaccine development has 
been slow46. Several obstacles to the successful development of a safe 
and effective RSV vaccine have been identified.  
           First, an ideal RSV vaccine would provide immunologic protection 
to infants less than 2 months of age. This challenge has led some 
investigators to advocate maternal immunization as a potential strategy. 
Next, natural infection with RSV does not induce complete and long 
lasting immunity. An RSV vaccine would be unlikely to induce long 
lasting immunity, but a reasonable goal might be for an RSV vaccine to 
protect the most vulnerable children younger than 2 years from serious 
disease. Finally, the potential for immunoenhancement upon second 
exposure to RSV antigens has been a serious obstacle to the successful 
development of an RSV vaccine. Recently, the Centres for Disease 
Control and Prevention recommended that all healthy children aged          
6 to 23 months receive the influenza vaccine47. Recent issues with the 
vaccine supply have limited the early adoption of this recommendation, 
so the magnitude of its impact remains unknown. Currently, 
paediatricians rely on passive immunization to prevent serious RSV 
related infections in high-risk infants. Monthly administration of 
paluvizumab (a monoclonal antibody directed against a key viral surface 
14 
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protein) or hyper immune immunoglobulin is associated with a 
significant reduction in the rate of hospitalization for respiratory illnesses 
among children younger than 2 years of age with a history of prematurity, 
chronic lung disease, and hemodynamically significant congenital heart 
disease48-50. RSV prophylaxis should be administered once per month 
during the RSV season. Because high-risk infants can develop two severe 
RSV infections within the same season, prophylaxis should be continued 
throughout the RSV season even in an infant who develops a documented 
RSV infection while receiving immunoprophylaxis. 
 
 
 
                               
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
 
REVIEW OF LITERATURE 
1) Iqbal SMJ, et al, 51 from King Edward Medical University/ Mayo 
Hospital, Lahore conducted an epidemiological and clinical study in 
acute bronchiolitis during October 2006 to March 2007.              
They mentioned that overwhelming majority of children suffering 
from acute bronchiolitis was less than one year of age. There was 
male predominance. Most of the children were bottle fed.           
Main presenting features of acute bronchiolitis were respiratory 
distress, nasal flaring and wheezing. 
 
2) Thorburn K, 52 from a tertiary paediatric intensive care unit in a 
university affiliated children's hospital, UK, had done a cohort study 
of children with severe RSV infection covering eight consecutive 
RSV seasons (1999-2007). They concluded that pre existing illness 
or co-morbidity, in particular multiple pre existing diseases and 
cardiac abnormality, is associated with a significantly higher risk of 
mortality from severe RSV infection. Hospital acquired RSV 
infection is an additional major risk factor for death in children with 
severe RSV infection. 
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3) Holman, et al, 53 during 1996 through 1998 reported 229 
bronchiolitis deaths, resulting in an average annual infant mortality 
rate of 2.0 per 100 000 live births in United States. The study 
showed that infants born as VLBW and LBW are at increased risk of 
dying with bronchiolitis. Although infants weighing less than 2500 g 
at birth are at increased risk for dying with bronchiolitis, the majority 
of bronchiolitis deaths occur among infants of normal birth weight. 
 
4) Shay DK, et al, 54 done a descriptive analysis of US National 
Hospital discharge survey data from 1980 to 1996 to describe rates 
of bronchiolitis associated hospitalizations during 1980-1996.       
The rates of hospitalization of children with bronchiolitis increased 
substantially, as did the proportion of total and lower respiratory 
tract hospitalizations associated with bronchiolitis.                   
Annual bronchiolitis hospitalizations associated with RSV infection 
among children may be greater than previous estimates for RSV 
bronchiolitis and pneumonia hospitalizations combined. 
 
5) Moore HC, et al, 55 conducted a retrospective population based 
cohort study of 212068 singleton births of 37 to 42 weeks gestation 
to examine the associations between the number of hospital 
admissions for bronchiolitis and pneumonia and elective caesarean 
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delivery. This study concluded that delivery by elective caesarean 
was independently associated with infant hospitalizations for 
bronchiolitis but not pneumonia. Elective caesarean delivery without 
labour may result in impaired immunity in the newborn leading to 
high risk of early viral lower respiratory infections. 
 
6) El-Radhi, et al, 56 from Queen Mary's Hospital, Sidcup, UK, studied 
the relationship between fever and the clinical course of 90 infants 
(59 boys, 31 girls) hospitalised during between November 1997 and 
February 1998 with bronchiolitis prospectively. The findings of this 
study suggest that most infants with bronchiolitis are afebrile and 
that fever is associated with more severe bronchiolitis. 
 
7) Koehoorn, et al, 57 analysed the outpatient and inpatient health 
records of 93058 infants born in the Georgia Air Basin between 
1999 and 2002 to investigate the epidemiological features of 
bronchiolitis. It is a population based cohort study. Adjusted Cox 
proportional-hazard analyses indicated an increased risk of 
bronchiolitis in the first year of life (follow-up period: 2 to 12 
months) for boys, infants of First Nations status, infants with older 
siblings and infants living in neighbourhoods with smaller 
proportions of maternal post secondary education. The risk also was 
18 
 
high for infants born to young mothers less than 20 years of age or 
mothers who did not initiate breastfeeding in the hospital.         
Infants with LBW or VLBW and those with underlying congenital 
anomalies also had increased risk. Maternal smoking during 
pregnancy increased the risk of hospitalized bronchiolitis.          
 
8) Semple MG, et al, 58 conducted a prospective cohort study in Alder 
Hey Children’s Hospital, UK with 378 infants admitted to hospital 
with a diagnosis of bronchiolitis over 3 consecutive endemic winter 
seasons (2002 - 2005) to examine demographic, environmental and 
clinical factors associated with severe bronchiolitis in infants 
admitted to hospital and quantify the independent effects of these 
factors.  Of the 378 infants, 299 (79%) were antigen positive to 
respiratory syncytial virus (RSV).    They found male sex (p = 0.035) 
and exposure to passive smoking (p = 0.001) were associated with 
severe disease. Premature birth, low birth weight, low admission 
weight and low corrected age on admission were also associated 
with need for mechanical ventilation (p = 0.002). 
 
9) Fjaerli HO, et al, 59 from Akershus University Hospital, Norway 
performed a population based retrospective survey for the period 
1993 to 2000 in children younger than two years of age hospitalised 
for RSV bronchiolitis. They concluded that the length of 
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hospitalisation and morbidity was high in preterm infants, children 
with a congenital heart disease and in children with trisomy 21, the 
last group being at particular high risk for severe disease. 
 
10)  Al-Muhsen SZ, et al, 60 investigated the risk factors associated with 
RSV infection in Saudi children admitted in pediatric intensive care 
unit (PICU) of a tertiary hospital during January 2003 to January 
2009. They have found that prematurity is associated with increased 
severity of RSV bronchiolitis.   37% of the infants admitted in the 
PICU were found to be of premature birth. Moreover, children with 
underlying pulmonary pathology and cardiac abnormalities were 
also more prone to RSV infection. 
11) Horn SD, et al, 61 from Salt Lake City, USA, analysed the data from 
304 infants (</=1 year) with RSV bronchiolitis or RSV pneumonia 
admitted to nine children's hospitals from April 1995 to September 
1996 retrospectively to determine the outcomes of infants 
hospitalized for respiratory syncytial virus (RSV) associated 
respiratory illnesses. They compared two 215 term infants            
(GA > or =37 weeks) and 89 infants with GA <37 weeks, divided 
according to GA into 3 subgroups (< or =32, 33 to 35, and 36 
weeks). They found significant differences for the rate of intubation 
(P=.002) and ICU and hospital length of stay (P=.021 and P<.0001, 
respectively), with the highest resource use in 33 to 35 weeks GA 
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infants, which remained significant in multiple regression analyses. 
The study concludes that, prematurity < or =35 weeks GA 
significantly increases the risk for severe outcomes among infants 
hospitalized for RSV. Infants 36 weeks GA had outcomes similar to 
term infants. 
12) Shaw KN, et al, 62 from the Division of General Pediatrics, 
Children's Hospital of Philadelphia, conducted a study with two 
hundred thirteen infants younger than 13 months with bronchiolitis. 
They were prospectively followed up to identify the historical, 
physical, and laboratory clues at initial emergency department 
evaluation that would help to predict disease severity. Based on their 
total course of illness, the patients were classified as having mild 
(139 patients) or severe (74 patients) disease, and the initial 
emergency department evaluation findings of these two groups were 
compared. They concluded that six independent clinical and 
laboratory findings were strongly associated with more severe 
illness: (1) "ill" or "toxic" general appearance; (2) oxygen saturation 
less than 95%, as determined by pulse oximetry;  (3) gestational age, 
younger than 34 weeks; (4) respiratory rate, 70/min or greater;       
(5) atelectasis on a chest roentgenogram; and  (6) age, younger than 
3 months. The infant's oxygen saturation as determined by pulse 
oximetry was the single best objective predictor of more severe 
disease.
  
 
 
 
 
 
 
 
STUDY JUSTIFICATION 
 
STUDY JUSTIFICATION 
 
 In healthy infants and young children acute bronchiolitis is usually 
a self limited disease. Treatment in most of these cases is only 
supportive measures. Most of these children begin to improve 
within one or two weeks. But it can lead to severe disease and 
mortality in some children. 
 If we know the factors which predispose to severe bronchiolitis and 
mortality in acute bronchiolitis, plan of management can be 
targeted effectively. 
 Keeping this in mind, this study was designed to study the clinical 
profile of acute bronchiolitis in our hospital and risk factors for 
severe disease and mortality in children less than 2 years of age. 
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AIM OF THIS STUDY 
 
 
AIM OF THIS STUDY 
 
 To describe the clinical profile and 
 To study the  risk factors for severity and mortality in infants and 
young children less than 2 years of age presenting with acute 
bronchiolitis at an urban referral hospital. 
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SUBJECTS AND METHODS 
 
SUBJECTS AND METHODS 
 
1. Methodology 
Study design 
            Descriptive study / Nested case control study. 
Study place 
            General medical wards and PICU, Institute of Child Health and 
Hospital for Children, Egmore, Chennai. 
Study period 
           January 2010 to October 2011 
Study population 
           Cases admitted with signs and symptoms of acute bronchiolitis in 
general medical wards and PICU of ICH and HC, Egmore, Chennai. 
Case definition63 
           Acute bronchiolitis is defined as the first episode of breathlessness 
in a child between 31 days to 24 months of age associated with the 
following signs and symptoms, 
1. Upper respiratory illnessess like cough, rhinorrhea 
2. With or without fever 
3. Respiratory distress 
- tachypnea (RR> or =60 / min in infants < 2 months 
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                             > or =50/ min in 2 months to 1 year 
                             > or =40 / min in children > 1 year) 
          -  Chest retractions, nasal flaring, grunting. 
4. Wheeze and crepitations 
5. With or without cyanosis 
6. Normal or hyperinflation in chest X ray 
7. No family h/o atopy, asthma. 
Mild bronchiolitis 
                               ■ Normal ability to feed 
                               ■ Little or no respiratory distress 
                               ■ No requirement for oxygen therapy –i.e. oxygen  
                                   saturation 92 percent or more in room air. 
                               ■ Will recover fully in one to two weeks. 
Moderate bronchiolitis 
                              ■ May appear short of breath during feeding. 
                                ■ Moderate respiratory distress, with some chest wall  
                                 retractions, nasal flaring. 
                             ■ May have apnoeic episodes, usually brief,   
                                self limiting. 
                                ■ Usually hypoxemic, corrected (to SpO2=92 per cent  
                                 or higher) by oxygen supplementation. 
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Severe bronchiolitis 
Severe acute bronchiolitis is defined as signs and symptoms of 
acute bronchiolitis with one or more of the following conditions, 
1. Poor feeding / Need for intravenous hydration 
2. Severe respiratory distress with marked retractions, nasal 
flaring, grunting 
3. Hypoxemia(SpO2 <92%) not correctable with oxygen 
supplementation. 
4. Need for mechanical ventilation. 
Inclusion criteria  
Children between the age group of 31 days  to 24 months who meet 
the case definition for acute bronchiolitis 
Exclusion criteria 
1. Children with abnormal chest X ray findings like 
consolidation, patch and cyst will be excluded. 
2. Children in whom structural malformations are identified 
such as CLE will be excluded. 
3. Children who have known immunodeficiency will be 
excluded. 
Cases   
           All cases of acute bronchiolitis, fulfilling the criteria for severe 
disease and those who have died. 
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Controls 
           All cases of mild and moderate acute bronchiolitis. 
Case : Control Ratio;     1: 2 
Sample size: 215 
 
2. Manoeuvre   
¾ Study population was recruited based on inclusion and exclusion 
criteria after obtaining parent consent. 
¾ Then they are subjected to clinical examination and graded into 
mild, moderate and severe cases and they were divided into severe 
(case) and non severe (control) groups.  
¾ Using prestructured proforma, information is gathered regarding 
patients age, sex, other demographic details and risk factors 
considered for this study from all patients. 
¾ The following demographic and clinical variables were compared 
between severe and non severe groups to asses their value as risk 
factors for severe disease. 
 
1. Age (less than 3 months) 
2. Male sex  
3. Poor socioeconomic status 
4. Family history of atopy 
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5. Upper respiratory illness in the family 
6. Indoor air pollution 
7. Exposure to passive smoking 
8. Caesarean delivery 
9. Preterm birth (less than 34 weeks) 
10. Low birth weight (less than 2.0 kg) 
11. History of neonatal admission 
12. History of neonatal mechanical ventilation 
13. Lack of breast feeding (those breastfed less than 3   
      months duration) 
14. Fever 
15. Underlying congenital cardiac lesions 
16. Underlying congenital airway anomalies 
17. Over weight (weight for length >2 z score) 
18. Clinical pallor 
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3. Statistical analysis   
• Statistical analysis was done using SPSS software with 17.0 
version. 
• Descriptive statistics like number, proportion, percentage, range 
and inferential statistics like p value was arrived at using Chi 
square test. 
• Univariate analysis with severity as the outcome variable was 
done. This provided an Odds Ratio with 95% confidence interval 
[OR(95%CI)] for each factor.  
• All the significant variables from univariate analysis were applied 
into the binary logistic regression model. Multivariate binary 
logistic regression models were constructed to identify associations 
between the environmental, demographic and clinical covariates 
and outcome measures (disease severity). 
 
4. Ethics  
                           Patient consent and IRB approval obtained 
  
 
 
  
 
 
 
 
 
OBSERVATIONS 
 
 
OBSERVATIONS 
 
Total cases studied   : 215 
Number of severe cases  :   48 
Number of non severe cases : 167 
Totally 215 children, diagnosed as bronchiolitis from January 2009 
to October 2011, were included in this study. Out of whom 137(63.7%) 
children were males, 78(36.3%) children were females with male to 
female ratio of 1.7:1.  
Figure  2: Comparison of  sex distribution of acute bronchiolitis among severe and non severe 
groups. 
 
Among these 215 children, 33 (15.3%) belong to less than 3 
months of age group, 92 (42.8%) children were between 3 and 6 months 
of age, 83(38.6%) children were between 6 and 12 months of age group, 
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7(3.3%) were belong to more than one year of age group. Lowest age 
reported was 35 days. The mean age reported in this study is 4.6 months.  
Figure 3: Comparison of  age distribution of acute bronchiolitis among severe and non severe 
groups. 
 
Most of these cases (83.3%) were reported between the months of 
October and January. Rest of the cases were spread throughout the year.  
Figure 4: Comparison of  seasonal pattern of acute bronchiolitis among severe and non severe                 
                                                                                  groups.  
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 79(36.7%) of these children required less than two days of 
hospitalisation, 88(40.9%) children stayed in the hospital for 2 to 5 days 
while 44(20.5%) children stayed for 5 to 10 days and only 4(1.9%) 
children required more than 10 days of hospitalisation. The mean 
duration of hospital stay is 3.52 days.  
    Figure 5: Comparison of duration of hospital stays of among severe and non severe groups. 
 
While looking into the socioeconomic status, 172 (80%) children 
in this study belong to middle (both upper middle and lower middle) 
socioeconomic status according to modified kuppusamy’s scale, whereas 
28(13%) of children belong to lower (both upper lower and lower) 
socioeconomic status and only 15(7.0%) of them belong to upper 
socioeconomic status.  
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        Figure 6: Comparison of socioeconomic profile among severe and non severe groups. 
 
All children in our study had upper respiratory illness in the form 
of cough, running nose or sneezing, of whom 185 (86.0%) children had 
upper respiratory symptoms for less than two days duration prior to 
hospitalisation, whereas 29 (13.5%) children had these symptoms 
between 2 to 5 days duration and only one child (0.5%) had symptoms for 
more than five days duration.  
Among these 215 children, fever was documented in 150(69.8%) 
children. Among those 150 febrile children 131(87.3%) of them had low 
grade fever (temperature recorded less than 101 degree F) and 19(12.7%) 
children had fever of high grade (more than or equal to 101 degree F) in 
nature. But none of these children had history of chills or rigors. In 
117(78.0%) children, the fever was present for less than 2 days duration, 
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while in 31(20.7%) children, the fever was present between 2 to 5 days 
duration and only 2(1.3%) children had fever for more than 5 days 
duration.  
             Figure 7: Comparison of presence of fever among severe and non severe groups. 
 
All 215(100%) children had history of difficulty in breathing. Out 
of them, 184(85.6%) of children had these symptoms for less than two 
days duration and 31(14.4%) children were symptomatic for 2 to 5 days 
duration. But none of these children had these symptoms for more than 5 
days duration.  
Among these 215 children, 10(4.7%) children had various forms of 
congenital cardiac lesions. 4 children were already diagnosed prior to this 
hospital admission but in other 6 children, the diagnosis was established 
during this present hospitalisation. Among these 10 children, 6 children 
34 
 
had ventricular septal defect, two children had atrial septal defect and 
another two of them had patent ductus arteriosus. 
      Figure 8: Comparison of congenital cardiac illness among severe and non severe groups. 
 
Congenital airway anomalies were present in 10(4.7%) children. 
Among these, eight children had laryngomalacia (5- already diagnosed, 
3- diagnosed at this time) and two children had tracheomalacia (both of 
them were diagnosed at this time). Among those with congenital cardiac 
lesions and congenital airway anomalies, the clinical course was longer 
and severe (p < 0.05). 
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           Figure 9: Comparison of airway anomalies among severe and non severe groups. 
 
  While analysing the family history of these 215 children, family 
history of upper respiratory illness in the form of cough, cold, sneezing or 
running nose in any member of the family (father, mother, grant parents 
or siblings) was present in 26(12.1%) cases. This is most commonly seen 
among those children, who had severe clinical course (p <.0.05)  
            Figure 10: Comparison of URI in the family among severe and non severe groups. 
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 Family history of smoking (in anyone of the family member) was 
present in 23(10.7%) cases.  
     Figure 11: Comparison of exposure to passive smoking among severe and non severe groups. 
 
Family history of allergy or atopy was present in 20(9.3%) cases. 
But this history was most commonly seen in those who had milder 
clinical course. Indoor air pollution was present in 21(9.8%) cases.  
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          Figure 12: Comparison of family history of atopy among severe and non severe groups. 
 
While probing into the birth and neonatal history, 137(63.70%) 
children were delivered by caesarean section and 78(36.30%) of children 
were delivered by normal vaginal delivery.  
         Figure 13: Comparison of type of delivery among severe and non severe groups. 
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Among them 189(87.90%) of children were delivered after 34 
completed weeks and 26(12.10%) of them were delivered before 34 
completed weeks.  
                  Figure 14: Comparison of gestational age among severe and non severe groups. 
 
While looking into the birth weight of these children, 180(83.70%) 
of children had birth weight of 2.0 to 4.0 kgs.  33(15.40%) children had 
birth weight of less than 2.0 kgs and 2(0.9%) children had birth weight of 
more than 4.0 kgs. 
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         Figure 15: Comparison of birth weight among severe and non severe groups. 
 
Out of these 215 children, 21(9.8%) had history of admission in the 
neonatal nursery. These babies were admitted in the neonatal nursery for 
various reasons like low birth weight, respiratory distress, preterm care, 
sepsis and etc. Among these 21 children, 9(4.2%) were ventilated in the 
newborn period. 
 
    Figure 16: Comparison of history of neonatal admission among severe and non severe groups. 
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Figure 17: Comparison of history of neonatal mechanical ventilation among severe and non 
severe groups. 
                      
 
Among these 215 children, 148(68.80%) children were fed 
exclusively with breast feeds for more than 3 months, but 67(31.20%) 
children were given breast feeds for less than 3 months period and given 
other type of feeds like cow’s milk, artificial feeds during the first six 
months period.  
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Figure 18: Comparison of duration of exclusive breast feeding of acute bronchiolitis among 
severe and non severe groups. 
  
On examination, 167(77.67%) children had normal mental status 
(alert) according to AVPU scale, 25(11.62%) children were found to be 
in verbal state, 18(8.37%) children were found in pain responsive state 
and 5(2.32%) children were found to be in unresponsive status. All these 
children (100%) had respiratory rate of more than normal for the 
corresponding age according to FIMNCI guidelines. Among these 215 
children, 205(95.30%) had chest in drawing. Nasal flaring was present in 
51(23.70%) children. 40(18.6%) children had grunting and cyanosis was 
present in 10(4.70%) children.  
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While analysing the anthropometric measurements of these 215 
children, 192(89.30%) children had age appropriate (between -2 z score 
to +2 z score) weight for length according to WHO growth standards, 
whereas 15(7.0%) children had their weight for length between +2 z score 
to +3 z score and 8(3.7%) children had their weight for length less than -2 
z score.  While analysing the length for age, 212(98.6%) children had 
normal values (between -2 z score to +2 z score), whereas in 3(1.4%) 
children the length falls below -2 z score. Clinical pallor was noticed in 
20(9.3%) children.  
            Figure 19: Comparison of weight for length among severe and non severe groups. 
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                      Figure 20: Comparison of pallor among severe and non severe groups. 
 
In our study, only 3(1.40%) children had recurrent apnoea which 
required intubation and mechanical ventilation. Refusal of feeds and 
vomiting were seen in 48(22.30%) and 33(15.30%) children respectively.  
         Figure 21: Comparison of need for ventilation among severe and non severe groups. 
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54(25.10%) children had tachycardia (heart rate more than normal range 
for age according to PALS guidelines). The blood pressure measurement 
of these children showed normal BP according to PALS guidelines in 
202(94%) children but 10(4.70%) children had high systolic pressure 
with wide BP and 3(1.4%) children had hypotension. Among these 215 
children, 39(18.1%) children presented in shock (25- fluid responsive 
shock, 8- dopamine responsive shock, 3- catecholamine responsive shock 
and 3- refractory shock) which required fluids and inotropic support. Out 
of them, 3 children presented with refractory shock and despite effective 
management and ventilatory support, they expired. 
 
Oxygen saturation was maintained more than 92% without oxygen 
in 136(63.3%) children, whereas 40(18.6%) children required oxygen up 
to 10 litres/min to maintain saturation more than 92% and 39(18.10%) 
children failed to maintain the saturation even with oxygen 
supplementation.  
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Figure 22: Comparison of oxygen saturation among severe and non severe groups. 
 
Wheeze and crepitations were present in 207 (96.3%) and 196 
(91.2%) children respectively. Hepatomegaly and splenomegaly were 
noted in 37(17.2%) and 7(3.3%) children respectively. Chest x ray 
showed bilateral hyperinflation in 182(84.65%) children and it was 
normal in 33(15.35%) children.  
 
97(45.10%) children in our study population, required intravenous 
hydration. Treatment with adrenaline aerosol therapy was given in 123 
children(57.20%), followed by salbutamol and hypertonic saline aerosol 
therapy in 84(39.10%) and 8(3.70%) children respectively. 
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The mean hospital stay in children treated with adrenaline, 
hypertonic saline and salbutamol nebulisation were 3.2 days, 3.55 days 
and 4.02 days respectively. Out of these 215 children, 21(9.8%) children 
needed assisted ventilation and 4 of them expired with a mortality rate of 
1.86%. 
 
Figure 23: Comparison of various types of nebulisation used among severe and non severe 
groups. 
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Risk factor analysis - Univariate analysis: 
Demographic, environmental and clinical characteristics of the 
participants were analysed for associations among disease severity 
groups. The result of this analysis is given in the table (1, 2, 3 and 4). 
Several factors are associated with severity and mortality of acute 
bronchiolitis.  
♦ Age group less than 3 months was found 10.04 times more 
commonly among severe bronchiolitis group when compared to the 
non severe group [OR(95%CI) = 10.04(4.43 – 22.77)] 
♦ Male sex was seen in 34(15.8%) and 103(47.9%) children among 
case and control groups respectively. But it is not statistically 
significant.  
♦ Fever was found (4.82 times) more commonly among severe 
bronchiolitis group when compared to the non severe group 
[OR(95%CI) = 4.82(1.81 – 12.83)] 
♦ Caesarean delivery was observed (2.61 times) more commonly 
among severe bronchiolitis group when compared to non severe 
group [OR(95%CI) = 2.61(1.21 – 5.59)]. 
♦ Preterm less than 34 completed weeks was more commonly 
observed (11.92 times) among severe bronchiolitis group when 
48 
 
compared to non severe group [OR(95%CI) = 11.92(4.75 – 
29.91)]. 
♦ Birth weight of less than 2.0 kilograms was more commonly 
observed (14.44 times) among severe bronchiolitis group when 
compared to non severe group [OR(95%CI) = 14.44(6.14 – 
33.92)].  
♦ History of admission in NICU in the neonatal period for various 
reasons was more commonly observed (5.85 times) among severe 
bronchiolitis group when compared to non severe group 
[OR(95%CI) = 5.85(2.29 – 14.93)]. 
♦ History of mechanical ventilation in the neonatal period for various 
reasons was more commonly observed (14.08 times) among severe 
bronchiolitis group when compared to non severe group 
[OR(95%CI) = 14.08 (2.82 – 70.34)].  
♦ Breastfeeding for less than 3 months duration was (3.63 times) 
more among severe bronchiolitis group when compared to non 
severe group [OR(95%CI) = 3.63(1.86 – 7.08)]. 
♦ History of upper respiratory illness in the family is was more 
commonly seen 7.85 times among severe bronchiolitis group when 
compared to non severe group [OR(95%CI) = 7.85(3.26 – 18.86)].  
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♦ Exposure to passive smoking was (9.03 times) more among severe 
bronchiolitis group when compared to non severe group 
[OR(95%CI) = 9.03(3.54 – 23.04)].  
♦ Underlying congenital cardiac lesions were more commonly 
observed (5.82 times) among severe bronchiolitis group when 
compared to non severe group [OR(95%CI) = 5.82(1.57 – 21.57)].  
♦ Underlying congenital airway anomalies were more commonly 
observed (16.5 times) among severe bronchiolitis group when 
compared to non severe group [OR(95%CI) = 16.5(3.37 – 80.71)].  
♦ Over weight and obesity (weight for length > +2 z score) were 
more commonly observed (12.11 times) among severe 
bronchiolitis group when compared to non severe group 
[OR(95%CI) = 12.11(3.63 – 40.17)].  
♦ Pallor was more commonly observed (6.62 times) among severe 
bronchiolitis group when compared to non severe group 
[OR(95%CI) = 6.62(2.52 – 17.38)].  
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Table 1: Comparison of demographic factors among severe and non    
               severe bronchiolitis groups – Univariate analysis. 
 
S.No 
 
Variable 
 
Severe    
disease 
n (%) 
 
Non severe 
disease 
n (%) 
 
OR 
(95% CI) 
 
P value 
 
 
1. 
 
Age       < 3 months 
              3 – 6 months 
              6 – 12 months 
              > 12 months 
 
 
21(43.75) 
22(45.83) 
5(10.42) 
0(0.0) 
 
12(7.19) 
70(41.91) 
78(46.71) 
7(4.19) 
 
10.04(4.43 – 22.77) 
1.17(0.61 – 2.23) 
0.13(0.05 – 0.35) 
- 
 
0.000 
 
2. 
 
Sex       Male 
             Female 
 
 
34(70.80) 
14(29.20) 
 
103(61.70) 
64(38.30) 
 
1.59(0.75 – 3.02) 
0.66(033 – 1.32) 
 
0.245 
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Table 2: Comparison of environmental factors among severe and non  
               severe bronchiolitis groups – Univariate analysis.       
 
S.No 
 
 
                                           
         Variable 
 
 
 
    Severe    
    disease 
     n(%) 
 
Non 
severe 
disease 
n(%) 
 
          OR 
      (95% CI) 
 
 
   P 
value 
 
 
1. 
 
SE status Upper 
              Upper middle 
              Lower middle 
              Upper lower 
              Lower  
1(2.1) 
32(66.70) 
11(22.90) 
4(8.30) 
0 
14(8.40)    
68(40.70) 
61(36.50)   
22(13.20) 
2(1.20) 
0.23(0.029 – 1.81) 
2.91(0.82 – 5.71) 
0.51(0.24 – 1.08) 
0.59(0.19 – 1.83) 
- 
0.130 
2. 
 
F/H Atopy 
 
2(4.16) 18(10.77) 0.35(0.08 – 1.60) 0.165 
3. 
 
Indoor air pollution 
 
8(16.70) 13(7.8) 2.36(0.91 – 6.10) 0.068 
4. 
 
URI in the family 
 
16(33.30) 10(6.0) 7.85(3.26 – 18.86) 0.000 
5. 
 
Passive smoking 
 
15(31.30) 8(4.8) 9.03(3.54 – 23.04) 0.000 
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Table 3: Comparison of perinatal factors among severe and non  
               severe bronchiolitis groups – Univariate analysis.       
 
S. 
No 
 
Variable 
 
Severe    
disease 
n (%) 
 
Non 
severe 
disease 
n (%) 
 
OR 
(95% CI) 
 
P 
value
 
1 
 
 
Delivery              LSCS 
                          NVD 
 
38(79.17) 
10(20.83) 
99(59.28) 
68(40.72) 
2.61(1.21 – 5.59) 
0.38(0.17 – 0.82) 
0.012 
2 
 
Gestational age   <34 wks 
                         >34 wks 
 
18(37.5) 
30(62.5) 
 
8(4.8) 
159(95.2) 
 
11.92(4.75 – 29.91) 
0.08(0.03 – 0.21) 
 
0.000 
3 
 
Birth weight         <2 kg 
                              2-4 kg 
                              > 4 kg 
 
23(47.9) 
25(52.1) 
0 
 
10(6.0) 
155(92.8) 
2(1.2) 
 
14.44(6.14 – 33.92) 
0.08(0.03 – 0.19) 
- 
 
0.000 
4 
 
H/O Neonatal admission 
 
12(25.0) 9(5.4) 5.85(2.29 – 14.93) 0.000 
5 
 
Neonatal mechanical  
ventilation 
 
7(14.6) 2(1.2) 14.08(2.82 – 70.34) 0.000 
6 
 
Breast feeding  < 3 month 
                      >3 month 
26(54.2) 
22(45.8) 
41(24.6) 
126(75.4) 
 
3.63(1.86 – 7.08) 
0.27(0.14 – 0.53) 
 
 
0.000 
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Table 4: Comparison of clinical factors among severe and non  
               severe bronchiolitis groups – Univariate analysis.       
 
S. 
No 
 
Variable 
 
Severe    
disease 
n (%) 
 
Non 
severe 
disease 
n (%) 
 
OR 
(95% CI) 
 
P 
value
 
 
1. 
 
URI Duration     < 2 days 
                           2 – 5 days 
                           > 5 days 
 
44(91.7) 
4(8.3) 
0 
 
141(84.4) 
25(15.0) 
1(0.6) 
 
2.02(0.67 – 6.12) 
0.51(0.17 – 1.56) 
- 
 
0.42 
 
2. 
 
Fever   
 
 
43(89.6) 
 
107(64.1) 
 
4.82(1.81 – 12.83) 
 
0.001
 
3. 
 
Fever duration    < 2 days 
                           2 – 5 days 
                           > 5 days 
 
 
39(90.7) 
4(9.3) 
0 
 
78(72.9) 
27(25.2) 
2(1.9) 
 
3.62(0.79 – 11.04) 
0.30(0.29 – 1.62) 
- 
 
0.55 
 
4. 
 
Dyspnea duration  < 2 days 
                              2 – 5 days
                              > 5 days 
 
45(93.75)
3(6.25) 
0 
 
139(83.23) 
28(16.76) 
0 
 
3.02(0.87 – 10.41) 
0.33(0.09 – 1.14) 
- 
 
0.068
 
5. 
 
Underlying congenital   
cardiac lesions   
 
6(12.5) 
 
4(2.39) 
 
5.82(1.57 – 21.57) 
 
0.003
 
6. 
 
Underlying airway     
anomalies 
 
 
8(16.67) 
 
2(1.9) 
 
16.5(3.37 – 80.71) 
 
0.000
 
7. 
 
Weight for    < -2 z score 
Length         -2 to +2z score 
                     > +2 z score 
 
3(6.25) 
34(70.83)
11(22.92)
 
5(2.99) 
158(94.61) 
4(2.40) 
 
2.16(0.49 – 9.38) 
0.13(0.05 – 0.34) 
12.11(3.63 – 40.17) 
 
0.000
 
8. 
 
Pallor  
 
 
12(25.0) 
 
8(4.8) 
 
6.62(2.52 – 17.38) 
 
0.000
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Multivariate analysis: 
Multivariate binary logistic regression analysis after adjustment for 
confounding factors shows that, infants with fever, caesarean delivery, 
mechanical ventilation in the newborn period and upper respiratory 
illness in the family were independently associated with increased risk of 
developing severe disease. The results are given in table 5. 
    
  Table 5: Comparison of risk factors among severe and non severe  
                    bronchiolitis groups – Multivariate analysis.       
 
S.No 
 
Variable 
 
OR(95%CI) 
 
Significance
 
1. 
 
Fever 
 
4.52 (1.05 – 19.32) 
 
Significant 
 
2. 
 
Caesarean delivery 
 
16.61(3.30 – 83.67) 
 
Significant 
3. Neonatal mechanical ventilation 18.24(1.14 – 52.52) Significant 
4. Upper respiratory illness in the family 15.26 (2.99 – 77.88) Significant 
 
 
 
  
 
 
 
 
 
DISCUSSION 
 
DISCUSSION 
 
Bronchiolitis is an acute, infectious disease of the upper and lower 
respiratory tract resulting in obstruction of the smaller airways. Although 
it may occur in all age groups, as the larger airways of older children and 
adults better tolerate mucosal edema and severe symptoms are usually 
only evident in young infants. It usually occurs in children less than two 
years of age and presents with coughing, wheezing, and shortness of 
breath often caused by respiratory syncytial virus. 
 
In our study, we have included 215 children who were diagnosed 
as bronchiolitis. Out of them, 167(77.67%) children had mild and 
moderate disease, whereas 48(22.33%) children had severe disease 
similar to El Radhi A, et al study56. Among those 48 children presented as 
severe disease, 4 of them died with a mortality rate of 1.86% similar to 
Thorburn K52 study, with a mortality rate of 1.7% and other studies 
showing mortality rate ranging from 0.5 to 7%. This wide range in 
mortality could be due to varying prevalence of pathogenic organisms in 
different regions of the world. 
 
In our study, 125(58.10%) children were belong to less than 6 
months of age which is comparable with Shay DK, et al study in which 
57% of cases were less than 6 months of age group54. The mean age 
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group in our study is 4.6 months which is comparable to El-Radhi A, et al 
study56. Out of 215 children in our study, 63.7% children were males and 
36.3% children were females similar to Al-Muhsen SZ, et al study60. 
Most of these cases (83.3%) were reported between the months of 
October to January. This seasonal pattern is comparable to Al-Muhsen 
SZ, et al study60. All children in our study presented with a short duration 
of upper respiratory illness in the form of cough, cold, sneezing or 
running nose along with breathing difficulty which similar to other 
studies51-60. Among the 215 children, fever was documented in 
150(69.8%) children in our study, of which 87.3% children had low grade 
fever, which is comparable to El-Radhi A, et al study56. The duration of 
hospital stay was ranging from 1- 15 days with a mean hospital stay of 
3.52 days, which is similar to El-Radhi A, et al study56, in which the 
mean duration of hospital stay was 3.3 days, whereas Fjaerli HO, et al 
study59 showed 4.0 days, as the mean duration of hospital stay. 
 
 In our study, congenital cardiac lesions and congenital airway 
anomalies were present in 10(4.7%) each. This is comparable with Fjaerli 
HO, et al study59. Family history of respiratory illness, exposure to 
passive smoking, indoor air pollution and family history of atopy were 
present in 26(12.10%), 23(10.70%), 21(9.80%) and 20(9.3%) cases 
respectively which is comparable with Al-Muhsen SZ, et al study60. 
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While analysing the perinatal history, preterm less than 34 completed 
weeks was present in 26(12.10%) children whereas Fjaerli HO, et al59, 
reported preterm births in 7.0% cases only.  
 
 Demographic, environmental and clinical characteristics of the 
study population were analysed for association with severity of illness 
using Pearson Chi-square test. While analysing the risk factors, age less 
than 3 months, presence of fever, caesarean delivery, preterm less than 34 
weeks, birth weight less than 2.0 kg, history of neonatal admission, 
history of neonatal mechanical ventilation, breast feeding for < 3 months 
duration, presence of respiratory illness in the family, exposure to passive 
smoking, underlying congenital cardiac lesions, underlying congenital 
airway anomalies, weight for height >+2 z score, presence of pallor were 
more commonly observed among severe disease group when compared to 
non severe group. While applying all these significant univariate 
variables into the binary logistic regression model, fever, caesarean 
delivery, neonatal mechanical ventilation and upper respiratory illness in 
the family became more significant (p < 0.05). So, these four factors such 
as fever, caesarean delivery, neonatal mechanical ventilation and upper 
respiratory illness in the family independently predict the severity of 
bronchiolitis.  
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Fever 
 In our study fever in infants with bronchiolitis was most commonly 
observed among severe bronchiolitis groups when compared to non 
severe group as similar to El-Radhi, et al study56. Fever is independently 
associated with increased severity of bronchiolitis. The findings of our 
study suggest that most infants with bronchiolitis are afebrile and that 
fever is associated with more severe bronchiolitis. Infants with           
RSV-associated bronchiolitis are often febrile at the time of presentation 
for medical care; in patients with adenovirus or influenza-associated 
bronchiolitis, however, fever is often higher than 39.8oC. A rise in body 
temperature by 1°C results in 10% increase in energy expenditure.    
These changes are accompanied by an increase in oxygen consumption of      
10–12% for every 1°C rise in temperature25. The necessity for oxygen 
supplementation was one of the main factors contributing to prolonged 
hospitalisation. It is possible that a reduction of body temperature by 
frequent use of antipyretic agents could reduce the oxygen requirement 
and possibly the degree of hypoxia56. 
 
Age less than 3 months 
In our study, age less than 3 months was most commonly observed 
among severe bronchiolitis groups when compared to non severe group. 
This is because of the less tolerability of the smaller airway to respiratory 
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distress in very young infants when compared to older infants. Other 
studies have shown the same result64-69.  
 
Preterm less than 34 weeks  
In our study, preterm birth less than 34 completed weeks was most 
commonly observed among severe bronchiolitis groups when compared 
to non severe group.  Other investigators like Shay DK, et al, Semple 
MG, et al, Flaerli HO, et al and Bradly JP, et al54,58,59,64 had given the 
same result. The probable reason could be the immaturity of the lungs 
with some degree of bronchopulmonary dysplasia and immaturity of the 
immune system35,70,71. But this needs further investigations for validation. 
 
Cigarette smoking 
 In our study, exposure to smoking in the post natal period was most 
commonly observed among severe bronchiolitis groups when compared 
to non severe group. Semple MG, et al, Bradly JP, et al and Lanari, et al 
studies also revealed postnatal exposure to smoking worsens the severity 
of RSV bronchiolitis infection in infants58, 64, 72. Moreover, a study done 
by Gurkan, et al73, in which nicotine levels were measured at index of 
hospital admission, showed that infants hospitalized for severe 
bronchiolitis were exposed more recently to cigarette smoke.     
According to 1997 economic analysis of the medical effects of smoking 
on children, 22000 hospitalizations and 1100 deaths from RSV occur 
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every year due to parental second hand smoke74. Smoking exposure has 
been shown to reduce pulmonary function and increases the airway hyper 
reactivity in children. Thus infants exposed to second passive smoke 
seem to have a predisposition to developing severe bronchiolitis after 
infection with RSV. 
 
Family history of upper respiratory illness 
In our study, family history of upper respiratory illness was most 
commonly observed among severe bronchiolitis groups when compared 
to non severe group. Family history of upper respiratory illness is 
independently associated with increased severity of bronchiolitis. 
Bronchiolitis is transmitted through droplets that contain viral particles. 
These are exhaled into the air by breathing, coughing, or sneezing. These 
droplets can be carried on the hands, where they survive and can spread 
infection for several hours. Marguet C, et al, 65 study states those viral  
co-infections in bronchiolitis raised cumulative pathogenic effect and 
consequently a more severe illness, although other hypotheses as 
successive infections or healthy carriage might be also supported75. So 
when there is an upper respiratory illness in the family, it will predispose 
to co-infection or successive infection and consequently severe disease. 
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Pallor 
In our study, pallor was most commonly observed among severe 
bronchiolitis group when compared to non severe group. Pallor was 
independently associated with increased severity of bronchiolitis. In 
anaemia there will be some degree of hypoxia which increases oxygen 
demand. In such situation, a child developes any respiratory pathology, 
which increases the oxygen demand, will lead to rapid deterioration in the 
clinical course. However, many studies not addressed this issue and hence 
there is a need for further studies to look into this aspect. 
 
Family history of atopy 
Our study shows that there is no significant association between 
family history of atopy and severity of bronchiolitis. Our results were 
based on overall family history of atopy/ allergy. A study done by         
La Via W et al76, mentions that overall family history of atopy does not 
significantly affects the length of stay or any other complications due to 
bronchiolitis. But in various other studies, family history of atopy is 
mentioned as a protective factor against severe disease64. However, their 
results were based on maternal atopy in the form of asthma and allergies. 
 
 
 
62 
 
Caesarean delivery 
  In our study, caesarean delivery was most commonly seen among 
severe bronchiolitis groups when compared to non severe group. 
Caesarean delivery was independently associated with increased severity 
of bronchiolitis and is similar to studies done by Moore HC, et al, Hitt E, 
et al55,77.  Act of normal labour promotes the production of various 
cytokines and stimulates the immune system in both the mother and the 
baby. Therefore the cytokine levels differs in a newborn baby delivered 
by elective caesarean delivery, as shown by the lower levels of 
interleukin (IL) 6 and IL-10 in their cord blood sample than in those who 
had a normal vaginal delivery55. This explains the reason for increased 
risk of severity in babies born of elective caesarean section. 
 
Associated CHD and airway anomalies 
 In our study, underlying congenital cardiac lesions and congenital 
airway anomalies were more commonly observed among severe 
bronchiolitis group when compared to non severe group and is similar to 
observations of Shay DK, et al, Semple MG, et al, Flaerli HO, et al and 
Perales AB, et al54,58,59,78. 
 
 
 
63 
 
Neonatal mechanical ventilation 
History of neonatal mechanical ventilation was most commonly 
observed among severe bronchiolitis group when compared to non severe 
group. History of neonatal mechanical ventilation is independently 
associated with severity of bronchiolitis. This is similar to observation of 
Perales AB, et al78. Neonatal mechanical ventilation and oxygen therapy 
causes injury to airway of newborn babies and the airway undergoes 
some degree of bronchopulmonary dysplasia. This predisposes these 
babies to develop severe disease35. 
 
Low birth weight 
Birth weight of less than 2.0 kilograms was most commonly 
observed among severe bronchiolitis group when compared to non severe 
group. This is probably related to their airway morbidity due to low birth 
weight in the newborn period. This is similar to Perales AB, et al study78. 
 
Over weight and obesity 
           Over weight and obesity were more commonly observed among 
severe bronchiolitis group when compared to non severe group. Obesity 
can profoundly alter respiratory mechanics, respiratory muscle function, 
lung volumes, control of breathing, and gas exchange79. The pulmonary 
function test in obese children will show restrictive pattern. There is a 
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reduction in functional residual capacity (FRC) and diffusion capacity in 
obese children80. So, the tolerability of these children to significant 
degree of respiratory distress is low when compared with normal 
children. This predisposes obese children to severity and mortality in 
acute bronchiolitis. However, many studies not addressed this issue and 
hence there is a need for further studies to look into this aspect. 
 
 
 
 
                                     
 
 
 
 
 
 
 
 
  
 
 
 
 
 
CONCLUSION
 
 
CONCLUSION 
 
 Clinical profile of acute bronchiolitis in our study correlates with 
other literature. 
 In our study, the following factors are the independent predictors of 
severity and mortality of acute bronchiolitis. 
1. Fever 
2. Caesarean delivery 
3. Neonatal mechanical ventilation 
4. Upper respiratory illness in the family.  
 If a child with acute bronchiolitis has the above mentioned risk 
factors, severity should be anticipated and the child should be 
monitored closely for signs of clinical deterioration. 
 Proper antenatal and neonatal care to reduce the neonatal morbidity 
may have a positive impact on outcome of bronchiolitis. 
 Creating awareness to the public regarding the separation of family 
members having upper respiratory illness from young infants will 
reduce severity of bronchiolitis.  
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LIMITATION
 
 LIMITATION 
 
Our study had few limitations as the case definition for 
bronchiolitis was based mainly on the clinical criteria without any 
laboratory confirmation of acute bronchiolitis due to non-availability of 
diagnostic facilities. 
 
 
 
 
 
 
 
 
 
67 
  
 
 
 
 
 
 
BIBLIOGRAPHY
 
BIBLIOGRAPHY 
 
1) Holman RC, Shay DK, Curns AT, et al. Risk factors for 
bronchiolitis-associated deaths among infants in the United States. 
Pediatr Infect Dis J 2003; 22: 483– 490. 
2) Henderson FW, Clyde WA, Collier AM, et al. The etiologic and 
epidemiologic spectrum of bronchiolitis in pediatric practice. J 
Pediatr 1979; 95: 183– 190. 
3) Kim HW, Arrobio JO, Brandt DC, et al. Epidemiology or 
respiratory syncytial virus infection in Washington, DC. Am J 
Epidemiol 1973; 98: 216– 225. 
4) Leader S, Kohlhase K. Recent trends in severe respiratory syncytial 
virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 
143(5 Suppl): S127–S132. 
5) Reese AC, James IR, Landau LI, et al. Relationship between 
urinary nicotinine level and diagnosis in children admitted to 
hospital. Am Rev Respir Dis 1992; 146:66– 70. 
6) Panitch HB, Callahan CW, Schidlow DV. Bronchiolitis in children. 
Clin Chest Med 1993; 14 :715– 731. 
7) Camilli AE, Holberg CJ, Wright AL, et al. Parental childhood 
respiratory illness and respiratory illness in their infants. Pediatr 
Pulmonol 1993; 16:275–280. 
 
 
8) Anderson LJ, Parker RA, Strikas RA, et al. Daycare center 
attendance and hospitalization for lower respiratory tract illness. 
Pediatrics 1988; 82:300–308. 
9) Perlstein PH, Kotagal UR, Boling C, et al. Evaluation of an 
evidence-based guideline for bronchiolitis. Pediatrics 1999; 
104:1334– 1341. 
10) Deshpande SA, Northern V. The clinical and health economic 
burden of respiratory syncytial virus disease among children under 
2 years of age in a defined geographical area. Arch Dis Child 
2003; 88:1065–1069. 
11) Glezen WP, Taber LH, Frank AL, et al. Risk of primary infection 
and reinfection with respiratory syncytial virus. Am J Dis Child 
1986; 140:543– 546. 
12) Loda FA, Clyde WAJ, Glezen WP, et al. Studies on the role of 
viruses, bacteria, and M. pneumoniae as causes of lower 
respiratory tract infections in children. J Pediatr 1968; 72:161–176. 
13) Foy HM, Cooney MK, Maletzky AJ, et al. Incidence and etiology 
of pneumonia, croup and bronchiolitis in preschool children 
belonging to a prepaid medical care group over a four-year period. 
Am J Epidemiol 1973; 97:80–92. 
 
 
14) Glezen WP, Loda FA, Clyde WA, et al. Epidemiologic patterns of 
acute lower respiratory disease of children in a pediatric group 
practice. J Pediatr 1971; 78:397–406. 
15) Korppi M, Kotaniemi-Syrjanen A, Waris M, et al. Rhinovirus-
associated wheezing in infancy: comparison with respiratory 
syncytial virus bronchiolitis. Pediatr Infect Dis J 2004; 23:995-
999. 
16) Freymouth F, Vabret A, Legrand L, et al. Presence of the new 
human metapneumovirus in French children with bronchiolitis. 
Pediatr Infect Dis J 2003; 22:92–94. 
17) Williams JV, Harris PA, Tollefson SJ, et al. Human 
metapneumovirus and lower respiratory tract disease in otherwise 
healthy infants and children. N Engl J Med 2004; 350:443– 450. 
18) Sznajer Y,Westcott JY,Wenzel SE, et al. Airway eicosanoids in 
acute severe respiratory syncytial virus bronchiolitis. J Pediatr 
2004; 145:115– 118. 
19) Ackerman BD. Acute bronchiolitis: a study of 207 cases. Clin 
Pediatr 1962; 1:61–81. 
20) Wohl MEB, Chernick V. Treatment of acute bronchiolitis. N Engl 
J Med 2003; 349:82– 83. 
 
 
21) Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-
associated hospitalizations among US children, 1980–1996. JAMA 
1999; 282:1440 –1446. 
22) Mallory MD, Shay DK, Garrett J, et al. Bronchiolitis management 
preferences and the influence of pulse oximetry and respiratory 
rate on the decision to admit. Pediatrics 2003; 111:E45– 51. 
23) Patel H, Platt RW, Pekeles GS, et al. A randomized, controlled 
trial of the effectiveness of nebulized therapy with epinephrine 
compared with albuterol and saline in infants hospitalized for acute 
viral bronchiolitis. J Pediatr 2002; 141:818– 824. 
24) Kellner JD, Ohlsson A, Gadomski AM, et al. Bronchodilators for 
bronchiolitis. Cochrane Database Syst Rev 2000; (2):CD001266. 
bronchiolitis: in-patient focus 1055 
25) Wainwright C, Altamirano L, Cheney M, et al. A multicenter, 
randomized, double-blind, controlled trial of nebulized epinephrine 
in infants with acute bronchiolitis. N Engl J Med 2003; 349:27–35. 
26) Hartling L, Wiebe N, Russell K, et al. A meta-analysis of 
randomized controlled trials evaluating the efficacy of epinephrine 
for the treatment of acute viral bronchiolitis. Arch Pediatr Adolesc 
Med 2003; 157:957–964. 
 
 
27) Springer C, Bar-Yishay E, Uwayyed K, et al. Corticosteroids do 
not affect the clinical or physiological status of infants with 
bronchiolitis. Pediatr Pulmonol 1990; 9:181 –185. 
28) Garrison MM, Christakis DA, Harvey E, et al. Systemic 
corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics 
2000; 105:E44. 
29) Van Woensel JB, van Aalderen WM, de Weerd W, et al. 
Dexamethasone for treatment of patients mechanically ventilated 
for lower respiratory tract infection caused by respiratory syncytial 
virus. Thorax 2003; 58:383– 387. 
30) Weinberger M. Corticosteroids for first-time young wheezers: 
current status of the controversy. J Pediatr 2003; 143:700–702. 
31) American Academy of Pediatrics Committee on Infectious 
Diseases. Reassessment of the indications for ribavirin therapy in 
respiratory syncytial virus infections. Pediatrics 1996; 97:137–140. 
32) Moscona A. Management of respiratory syncytial virus infections 
in the immunocompromised child. Pediatr Infect Dis J 2000; 
19:253–254. 
33) Smith DW, Frankel LR, Mathers LH, et al. A controlled trial of 
aerosolized ribavirin in infants receiving mechanical ventilation for 
severe respiratory syncytial virus infection. N Engl J Med1991; 
325:24–29. 
 
 
34) Fitzgerald DA, Kilham HA, Bronchiolitis: assessment and 
evidence-based management, Clinical Update. mja.com.au | The 
Medical Journal of Australia, MJA 2004; 180 (8): 399-404. 
35) Grimaldi M, Gouyon B, Michaut F, et al. Severe respiratory 
syncytial virus bronchiolitis: epidemiologic variations associated 
with the initiation of palivizumab in severely premature infants 
with bronchopulmonary dysplasia. Pediatr Infect Dis J 2004; 
23:1081–1085. 
36) Korppi M, Piippo-Savolainen E, Korhonen K, et al. Respiratory 
morbidity 20 years after RSV infection in infancy. Pediatr 
Pulmonol 2004; 38:155–160. 
37) Hegele RG, Ahmad HY, Becker AB, et al. The association 
between respiratory viruses and symptoms in 2-week-old infants at 
high risk for asthma and allergy. J Pediatr 2001; 138:831– 837. 
38) Bont L, Steijn M, van Aalderen WM, et al. Impact of wheezing 
after respiratory syncytial virus infection on health-related quality 
of life. Pediatr Infect Dis J 2004; 23:414– 417. 
39) Lemanske RF. Viruses and asthma: inception, exacerbation, and 
possible prevention. J Pediatr 2003; 142:S3– 8. 
40) Gern JE. Mechanisms of virus-induced asthma. J Pediatr 2003; 
142:S9–14. 
 
 
41) Sampalis JS. Morbidity and mortality after RSV-associated 
hospitalizations among premature Canadian infants. J Pediatr 
2003; 143(5 Suppl):S150 – 156. 
42) Melendez E, Harper MB. Utility of sepsis evaluation in infants 90 
days of age or younger with fever and clinical bronchiolitis. 
Pediatr Infect Dis J 2003; 22:1053– 1056. 
43) Purcell K, Fergie J. Concurrent serious bacterial infection in 2396 
infants and children hospitalized with respiratory syncytial virus 
lower respiratory tract infection. Arch Pediatr Adolesc Med 2002; 
156:322– 324. 
44) Titus MO, Wright SW. Prevalence of serious bacterial infection in 
febrile infants with respiratory syncytial virus infection. Pediatrics 
2003; 112:282– 284. 
45) Levine DA, Platt SL, Dayan PS, et al. Risk of serious bacterial 
infection in young febrile infants with respiratory syncytial virus 
infections. Pediatrics 2004; 113:1728– 1734. 
46) Coffin SE, Offit PA. New vaccines against mucosal pathogens: 
rotavirus and respiratory syncytial virus. Adv Pediatr Infect Dis 
1997; 13:333– 348. 
47) Harper SA, Fukuda K, Uyeki TM, et al, Centers for Disease 
Control and Prevention (CDC) Advisory Committee on 
 
 
48) Navas L, Wang E, deCarvalho V, et al. Improved outcome of 
respiratory syncytial virus infection in a high-risk hospitalized 
population of Canadian children. Pediatric Investigators 
Collaborative Network on Infections in Canada.  J Pediatr 1993; 
121:348– 354. 
49) Meissner HC, Long SS, American Academy of Pediatrics 
Committee on Infectious Diseases and Committee on Fetus and 
Newborn. Revised indications for the use of palivizumab and 
respiratory syncytial virus immune globulin intravenous for the 
prevention of respiratory syncytial virus infections. Pediatrics 
2003; 112:1447–1452. 
50) Willson DF, Landrigan CP, Horn SD, et al. Complications in 
infants hospitalized for bronchiolitis or respiratory syncytial virus 
pneumonia. J Pediatr 2003; 143:S142– 149. 
51) Iqbal SMJ, Afzal MF, Sultan M. Acute Bronchiolitis: 
Epidemiological and Clinical Study, ANNALS VOL 15. NO. 4 
OCT. - DEC. 2009.  
 
 
52) Thorburn K. Pre-existing disease is associated with a significantly 
higher risk of death in severe respiratory syncytial virus infection. 
Arch Dis Child.  2009; 94(2):99-103 (ISSN: 1468-2044). 
53) HOLMAN, et al. The Pediatric Infectious Disease Journal:June 
2003 - Volume 22 - Issue 6 - pp 483-489. 
54) Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson 
LJ. Bronchiolitis-associated hospitalizations among US children, 
1980-1996. JAMA. 1999 Oct 20; 282(15):1440-1446. 
55) Moore HC, Klerk N, Holt P, Richmond PC, Lehmann D. 
Hospitalisation for bronchiolitis in infants is more common after 
elective caesarean delivery, Arch Dis Child doi:10.1136/ 
archdischild-2011-300607. 
56) El-Radhi A, Barry W, Patel S. Association of fever and severe 
clinical course in bronchiolitis, Arch Dis Child. 1999 
September; 81(3): 231–234. 
57) Koehoorn M, Karr CJ, Demers PA, Lencar C, Tamburic L, Brauer 
M. Descriptive Epidemiological Features of Bronchiolitis in a 
Population-Based Cohort, PEDIATRICS Vol. 122 No. 6 Dec 1, 
2008 pp. 1196 -1203 (doi: 10.1542/peds.2007-2231). 
58) Semple MG, Taylor-Robinson DC, Lane S, Smyth RL. Household 
Tobacco Smoke and Admission Weight Predict Severe 
Bronchiolitis in Infants Independent of Deprivation: Prospective 
 
 
Cohort Study, PLoS ONE | www.plosone.org, July 2011 | Volume 
6 | Issue 7 | e22425. 
59) Fjaerli HO, Farstad T, Bratlid D. Hospitalisations for respiratory 
syncytial virus bronchiolitis in Akershus, Norway, 1993–2000: a 
population-based retrospective study, BMC Pediatrics 2004, 4:25, 
http://www.biomedcentral.com/1471-2431/4/25. 
60) Al-Muhsen SZ. Clinical profile of Respiratory Syncytial Virus 
(RSV) bronchiolitis in the intensive care unit at a Tertiary Care 
Hospital, Curr Pediatr Res 2010; 14 (2): 75-80. 
61) Horn SD, Smout RJ. Effect of prematurity on respiratory syncytial 
virus hospital resource use and outcomes. J Pediatr.  2003; 143(5 
Suppl):S133-141 (ISSN: 0022-3476). 
62) Shaw KN, Bell LM, Sherman NH. Outpatient assessment of 
infants with bronchiolitis. Am J Dis Child.  1991; 145(2):151-
155 (ISSN: 0002-922X). 
63) Clinical practice guidelines, NSW health, assessment & 
management of acute bronchiolitis.  
Error! Hyperlink reference not valid.. 
 
 
 
 
 
 
64) Bradley JP, Bacharier LB, Bonfiglio J, Schechtman KB, Strunk 
R, Storch G, Castro M. Severity of respiratory syncytial virus 
bronchiolitis is affected by cigarette smoke exposure and atopy. 
Department of Internal Medicine, Washington University School 
of Medicine, St Louis, Missouri 63110-1093, USA. 
Pediatrics. 2005 Jan;115(1):e7-14.  
65) Marguet C, Lubrano M, Gueudin M, Le Roux P, Deschildre A. 
(2009) In Very Young Infants Severity of Acute Bronchiolitis 
Depends On Carried Viruses. PLoS ONE 4(2): e4596. 
doi:10.1371/journal.pone.0004596. 
66) Marlais M, Evans J, Abrahamson E. Clinical predictors of 
admission in infants with acute bronchiolitis, Paediatric infectious 
diseases Thorax 2010;65:A15 doi:10.1136/thx.2010.150912.28. 
67) Lebel MH, Gauthier M, Lacroix J. Respiratory failure and 
mechanical ventilation in severe bronchiolitis. Arch Dis Child 
1989; 64:1431–1437. 
68) O’Dempsey TJD, Laurence BE, McArdle TF, et al. The effect of 
temperature reduction on respiratory rate in febrile illnesses. Arch 
Dis Child 1993; 68:492–495. 
69) Outwater KM, Crone RK. Management of respiratory failure in 
infants with acute viral bronchiolitis. Am J Dis Child 1984; 
138:1071–1075. 
 
 
70) Zaw W, McDonald J. Respiratory syncytial virus bronchiolitis in 
ex-preterm infants in the Scottish highlands: review of hospital 
admissions and an analysis of hospital cost. Scottish Medical 
Journal (2003) Volume: 48, Issue: 4, Pages: 108-110. 
71) Siezen CL, et al. Genetic susceptibility to respiratory syncytial 
virus bronchiolitis in preterm children is associated with airway 
remodeling genes and innate immune genes. Laboratory for Health 
Protection Research, National Institute for Public Health and the 
Environment, Bilthoven, The Netherlands. Pediatr Infect Dis 
J. 2009 Apr; 28(4):333-335. 
72) Lanari M, Giovannini M, Giuffre L, et al. Prevalence of 
respiratory syncytial virus infection in Italian infants hospitalized 
for acute lower respiratory tract infections, and association 
between respiratory syncytial virus infection risk factors and 
disease severity. Pediatr Pulmonol. 2002; 33:458 – 46. 
73) Gurkan F, Kiral A, Dagli E, Karakoc F. The effect of passive 
smoking on the development of respiratory syncytial virus 
bronchiolitis. Eur J Epidemiol. 2000; 16:465– 468. 
74) Aligne C, Stoddard J. Tobacco and children. An economic 
evaluation of the medical effects of parental smoking. Arch Pediatr 
Adolesc Med. 1997; 151:648 – 653. 
 
 
75) Kusel MMH, de Klerk NH, Holt PG, Kebadze T, Johnston SL, et 
al. (2006) Role of respiratory viruses in acute upper and lower 
respiratory tract illness in the first year of life. A birth cohort 
study. Pediatr Infect Dis J 25: 680–686. 
76) La Via W, Grant S, Stutman H, Marks M. Clinical profile of 
pediatric patients hospitalized with respiratory syncytial virus 
infection. Clin Pediatr (Phila). 1993; 32:450 – 454. 
77) Hitt E. Cesarean Delivery\ Linked to Infant Bronchiolitis, Arch 
Dis Child. Published online October 28, 2011 
78) Perales AB. Perinatal history and hospitalization for bronchiolitis. 
A comparison with the impact-RSV Study Group. An Esp 
Pediatr. 2000 Dec; 53(6):527-532. 
79) Koenig SM. Pulmonary complications of obesity. Am J Med 
Sci. 2001 Apr; 321(4):249-279. 
 
80) Li A, Chan D, Wong E, Yin J, Nelson E, and Fok T. The effects 
of obesity on pulmonary function. Arch Dis Child. 2003 
April; 88(4): 361–363. 
 
 
 
 
 
 
 
 
 
ANNEXURE 
                                      I. PROFORMA 
   1.  Patient name  
   2.  Age / Sex  
   3.  IP. No  
   4.  Ward no  
   5.  Address 
 
 
   6.  Date / Time of admission  
   7.  Income  
   8.  Socioeconomic status  
CLINICAL HISTORY 
  9. H/O Upper respiratory illness a) yes                b) no
If yes, duration  
           Type  
 
 10. H/O Fever a) yes                 b) no
If yes, duration  
           Grade a) low                 b) high
           Chills& rigors a) present            b) absent 
 11. Breathing difficulty a) yes                   b) no
If yes,  duration  
12. Any known cardiac disease a) yes                   b) no
If yes, type of disease  
   Any treatment taken  
13. Any known lung disease a)yes                     b) no
If yes, duration  
Any treatment taken  
 
BIRTH HISTORY 
14. Type of delivery  a) preterm   b) term    c) post term 
If preterm, gestational age  
15 Nature of delivery a)LSCS     b)NVD
16. Birth weight  
17. Neonatal complications  
18. Neonatal mechanical ventilation a) yes               b) no
FEEDING HISTORY 
 19. Type of feed giving     
 20. How long exclusively breastfed  
 21. When was weaning started  
 
 
FAMILY HISTORY 
 22. Any H/O respiratory illness in the 
family 
a)yes                  b) no
 If yes, type of illness  
 23. H/O Smoking in the family a)yes                b) no
24. Indoor air pollution a)yes                b) no
 25. Family H/O Atopy, asthma  
CLINICAL EXAMINATION 
26. Level of consciousness  
27. Hydration status  
28. Weight for height  
29. Height for age  
30. Edema  a) yes               b) no
31. Shock  a) yes               b) no
32. Pallor  a) yes               b) no
33. Respiratory distress a) yes               b) no
If yes, severity  
34. Patients own respiration a) adequate          b)inadequate 
35. whether intubated  a) yes                    b) no
36. Chest retractions a) yes                    b) no
If yes, severity  
37. Nasal flaring a) yes                    b) no
If yes severity   
38. Grunting a) yes                     b) no
If yes, severity  
39. 
 
Cyanosis a) yes                       b) no 
If yes, type  
40. Apnea a) yes                      b) no 
 If yes, no of episodes  
 Duration of each episode  
41. Poor feeding a) yes                      b) no 
42. Pulse Rate  
Rhythm  
Type  
Grade  
43. Respiratory rate  
44. Temperature  
45. Blood pressure  
46. Nutritional status  
47. SPO2  
 
 
48. Respiratory system  
        Examination 
 
 
49. X ray finding  
TREATMENT 
50. O2 given a) yes                          b) no 
 Rate  
51. Diet a) oral feeds           b) IV fluids 
 
52. If IV fluids, type of fluid  
 
Rate   
 
53. Nebulisation given a) yes                           b) no 
54. Adrenalline / salbutamol /hypertonic 
saline 
 
55. Antibiotics prescribed a) yes                           b) no 
 
56. Specify drug and dose  
 
 
 
DISCHARGE FORM 
 
 1. Patient name  
 2. IP no  
 3. Date of discharge  
 4. Final diagnosis 
 
 
 
 5. Clinical status at discharge 
 
 
 
 6. Prescribed drugs at discharge 
 
 
 
 7. Any underlying illness 
 
 
                      
 
 
 II. ABBREVIATIONS 
 
RSV  - Respiratory Syncytial Virus 
LBW  - Very Low Birth Weight 
LBW  - Low Birth Weight 
PICU  - Pediatric Intensive Care Unit 
ICU  - Intensive Care Unit 
GA  - Gestational Age 
ICH & HC - Institute of Child Health and Hospital for Children 
CLE  - Congenital Lobar Emphysema 
OR (95%CI)- Odds Ratio(95%Confidence Interval) 
AVPU Scale- Alert, Verbal, Pain responsive, Unresponsive scale 
FIMNCI      - Facility Based Integrated Management of  
                                Neonatal and Childhood Illness 
WHO  - World Health Organization 
PALS  - Pediatric Advanced Life Support 
BP  - Blood Pressure 
NICU  - Neonatal Intensive Care Unit 
SE Status - Socio Economic Status 
URI  - Upper Respiratory Illness 
LSCS  - Lower Segment Caesarean Section 
NVD  - Normal Vaginal Delivery 
                      
 
 
 
                                   INFORMATION SHEET 
 
The clinical profile of Acute bronchiolitis in our hospital and 
risk factors for severe disease and mortality in children 31 
days to 24 months of age. 
 
                 Investigator name   : Dr. S. Palanivel 
 
                 Guides                     : Prof. M. Raghunadan, MD, DCH.                
                                              Dr. K. Nedunchelian,  MD, DCH.          
                                              Dr. S. Geetha,  MD, DCH. 
                                              Dr.P.Umakanthan, MD, DCH. 
 
                  (To be read to caretakers in the presence of witness) 
 
Yours child is suspected to have acute bronchiolitis infection. Acute 
bronchiolitis is predominantly a viral disease. It is one of the leading 
causes of hospitalisation in infants and young children. It occurs usually 
between 1 month to 24 months of age with a peak incidence between 3 to 
6 months of age.  
 
In healthy infants and young children acute bronchiolitis is usually a self 
limited disease. Treatment in most of these cases consists only supportive 
measures. Most of these children begin to improve within one or two 
weeks. But it can lead to severe disease and mortality in some children. 
 
If we know the factors which predisposing to severe bronchiolitis and 
mortality due to acute bronchiolitis, plan of management can be targeted 
effectively. 
 
This study will describe the clinical profile of acute bronchiolitis in our 
hospital and risk factors for severe disease and mortality in children 31 
days to 24 months of age. 
 
How is the study being done? 
 
If your child is suspected to have acute bronchiolitis, he/she will be 
subjected into thorough clinical examination and according to the 
findings he/she will be graded into mild or moderate or severe case. 
 
 
 
 
 
 
Using patient data entry form, information is gathered regarding patients 
age, sex, other demographic details and risk factors considered for this 
study  
 
If he/she has mild or moderate disease, he/she will be included in the 
control group. If he/she has severe disease he/she will be included in the 
case group. 
 
The risk factors are compared between cases and controls and adjusted 
OR with 95% CI will be arrived by multivariate analysis for each risk 
factor. 
 
Can I refuse to join the study? 
 
You may refuse to participate or withdraw from the study at any time. In 
both cases your child will be treated in the usual manner in this hospital. 
 
Is there benefit or harm to be in this study? 
 
By this study we can identify the clinical profile of acute bronchiolitis 
and risk factors for severe disease and mortality in our settings. 
 
If we know the factors which predisposing to severe bronchiolitis and 
mortality due to acute bronchiolitis, plan of management can be targeted 
effectively. 
 
There is no harms to the patients in this study. 
 
Confidentiality: 
 
The data collected from the study will be used for the purpose of the 
study only. The results of the study are to be published. Personal 
information of the children participating in the study will be kept 
confidential. There will not be any disclosure about yours childs 
information without your permission.  
 
Subject rights: 
 
I understood that if I wish further information regarding my childs rights 
as a research subject, I may contact the hospital where the study is taking 
place.  
 
 
 
               INFORMED CONSENT FORM 
 
I have been fully informed about the study and the benefits of this study 
and the possible harm that can happen. I understand that the doctor will 
ask questions and examine my child to make sure it is safe for him/her to 
enter the study. 
 
This authorization is valid for this study. “I have understood and received 
a copy of this consent form”. I agree for my child’s participation in this 
research study. 
 
 
Signature / Thumb print of parent or guardian: 
 
 
Signature of investigator:   
 
 
Witness signature: 
 
 
Date: 
 
 
Principal investigator:   
 
 
Address:  
 
 
 
 
Phone number: 
    
 
 
 
  
 
